A research-based look at four telehealth programs offering access to prescription weight-management treatment when a licensed healthcare provider determines it is appropriate.
We compared access, provider involvement, treatment formats, pricing structure and ongoing support—not promised weight-loss outcomes.
Curex combines an online medical intake, provider review, prescription access when appropriate, medication fulfillment and ongoing support within one telehealth workflow.
Gala GLP provides a fully online pathway with licensed-provider review and currently lists compounded GLP-1/GIP treatment along with selected branded options.
BreezeMeds uses a quick online assessment, medical consultation and delivery/support model. Its current site lists both injectable and oral weight-management formats.
AltRx starts with a short online assessment, followed by licensed-provider review and, when appropriate, prescription fulfillment through a licensed pharmacy.
| Provider | Care Model | Listed Formats | Provider Review | Support |
|---|---|---|---|---|
| Curex | Online telehealth | Injectable + oral compounded options | Yes | Ongoing follow-up access |
| Gala GLP | Online telehealth | Compounded GLP-1/GIP + selected branded options | Yes | Ongoing support |
| BreezeMeds | Online telehealth | Injectable + oral options listed | Yes | Delivery & support model |
| AltRx | Online telehealth | Compounded semaglutide / tirzepatide | Yes | Care-team support |
Because all four options involve medical care, we focused on practical program differences rather than ranking the medications themselves. A telehealth service can make access more convenient, but the actual prescription decision belongs to the licensed provider reviewing the patient's medical information.
Curex earns the #1 placement in this comparison because its current program information is unusually clear about the steps involved: complete a medical-history form, receive provider review, receive medication if prescribed, and maintain access to follow-ups and support.
The service also lists both injectable and oral compounded semaglutide and tirzepatide formats. Curex currently states that its published pricing includes the prescription and medication without a separate membership fee, although prices and availability should always be confirmed directly before enrollment.
Gala GLP is built around a streamlined online model. The brand currently states that licensed providers are available in all 50 states and lists compounded GLP-1/GIP treatment alongside selected brand-name options. Treatment still depends on eligibility and the provider's clinical judgment.
BreezeMeds highlights a simple online sequence: questionnaire, medical consultation, then delivery and support if treatment is prescribed. Its current site lists injectable and oral formats, which may appeal to people comparing different administration preferences.
AltRx uses an assessment and provider-review process and currently lists compounded semaglutide and compounded tirzepatide. When prescribed, medication is fulfilled by a licensed pharmacy, and the brand includes ongoing care-team support as part of its membership model.
Before enrolling, confirm your state is supported, which medication formats are currently available, the full recurring cost, whether the quoted price includes provider visits and medication, which pharmacy fulfills the prescription, cancellation rules, and how follow-up care works.
For compounded medications, it is also important to understand that compounded drugs are not FDA-approved. Ask the provider questions about the pharmacy, formulation, dosing instructions and monitoring process.
This comparison uses information available on the four brands' official websites in September 2026. We reviewed each service's stated access process, provider involvement, treatment formats, fulfillment model and support structure.
No. Prescription treatment is provided only when a licensed healthcare professional determines it is medically appropriate and applicable eligibility requirements are met.
No. Compounded medications are not FDA-approved. They are prepared by compounding pharmacies under applicable legal and pharmacy requirements and should not be represented as FDA-approved alternatives.
No. Treatment availability, formulation and brand-name or compounded options differ by service and can change. The provider ultimately determines which treatment, if any, is appropriate.
No. Consider provider access, pharmacy fulfillment, medication format, follow-up care, state availability, cancellation terms and the total recurring cost.